JC
GILD icon

JB Capital’s Gilead Sciences GILD Stock Holding History

JB Capital’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-3,763
Closed -$224K – 237
2022
Q1 		$224K Sell
3,763
-400
-10% -$25.6K 0.02% 226
2021
Q4 		$302K Sell
4,163
-70
-2% -$4.82K 0.03% 210
2021
Q3 		$296K Buy
+4,233
New +$297K 0.04% 236

Other funds holding GILD

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $185B AUM 39.58% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

JB Capital's GILD Position: Q2 2022 in Review

JB Capital sold out of Gilead Sciences (GILD) in Q2 2022, closing a stake of 3,763 shares — an estimated $224K sold.

JB Capital first reported a position in GILD in Q3 2021 and held it in 3 quarters. The position peaked at $302K in Q4 2021. 1,603 funds tracked by Wall St. Rank hold GILD as of Q2 2022.

  • JB Capital reported no remaining Gilead Sciences position as of Q2 2022 after selling out during the quarter.
  • JB Capital sold 3,763 Gilead Sciences shares in Q2 2022, an estimated $224K.
  • JB Capital first reported a position in Gilead Sciences in Q3 2021 and held it in 3 quarters.
  • JB Capital's Gilead Sciences position peaked at $302K in Q4 2021.
  • 1,603 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2022.

Based on JB Capital's 13F filing for Q2 2022, filed 28 Jul 2022.